Thank you,
@Trish , on both counts.
Congrats to
@Robert 1973 and the other authors. I really enjoyed reading everyone's points. When the letters are read together, a few themes emerge - the modesty of the reported changes in CFQ and SF36 PF scores, the adherence question, safety/harm and the need for objective measures. They read like a primer for critically reviewing trials of behavioural interventions for ME. Robert, I think yours will educate many about PEM!
If I’d had more than 250 words, I would have liked to cite Collin and Crawley’s (2017) data from adults who had undergone “specialist treatment of chronic fatigue syndrome/ME” at NHS specialist centres.
Patients who reported
improvement at 2, 3, 4 or 5 year follow-up, in the form of reporting that their overall health was much better or very much better than it had been before they had “specialist treatment”, had a median baseline SF36 PF of
52.
Patients who reported
no change at 2, 3, 4 or 5 year follow-up, in the form of reporting little or no change in their overall health, had a median baseline SF36 PF of
47.
Patients who reported
worsening at 2, 3, 4 or 5 year follow-up, in the form of reporting that their overall health was much worse or very much worse, had a median baseline SF 36 PF of
29.5.
See table 5:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513420/table/Tab5/
Full paper:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513420/
These data suggest that those with worse physical functioning at baseline do worse with "specialist treatment", not better, than those with higher baseline physical functioning, in line with my argument in my letter.